author-photo

Mathias Loft

University of Copenhagen

6

Papers

18

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Semi-automatic tumor delineation for evaluation of 64Cu-DOTATATE PET/CT in patients with neuroendocrine neoplasms: prognostication based on lowest lesion uptake and total tumor volume.

2021 The Journal of Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (0)
A randomised, factorial phase II study to determine the optimal dosing regimen for 68 Ga-satoreotide trizoxetan as an imaging agent in patients with gastroenteropancreatic neuroendocrine tumours.

2021 The Journal of Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (2)
Initial Experience with 64Cu-DOTATATE Digital PET of Patients with Neuroendocrine Neoplasms: Comparison with Analog PET

2021
Show All
- Source
- Cite
- Save
Citations (2)
64Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours Post-Injection.

2020 The Journal of Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (6)
64Cu-DOTATATE PET/CT and prediction of overall and progression-free survival in patients with neuroendocrine neoplasms

2020 The Journal of Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (8)